Icon PLC
ICLR
164.08
+2.39
+1.48%
Icon PLC
US · ICLR
#1235 by market cap
Listed 1970
164.08
+2.39
+1.48%
Live - 5344 symbols - heartbeat 124s ago
· 2026-10-07 19:54
After-hours
164.08
0.00%
- Market cap
- 12.66B
- P/E (TTM)i
- 252.43
- P/Bi
- 1.35
- EPSi
- 2.90
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on ICLR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.6 percentage points.
Institutional ownership
- Held by institutions
- 108.26% -0.63pp
- Institutions
- 535 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund92.52%
Hedge Fund9.56%
Public Company2.04%
Sovereign Wealth Fund1.10%
Government Pension Fund1.09%
Private Company1.02%
VC/PE Fund0.65%
Family Office/Trust0.26%
Top holders as of 2026-06-30
Artisan Partners Limited Partnership
11.19% · 8.64M sh
Wellington Management Group
6.90% · 5.32M sh
FMR
6.79% · 5.24M sh
Invesco Ltd.
6.72% · 5.19M sh
Harris Associates L.P.
5.79% · 4.47M sh
Brave Warrior Advisors, LLC
4.09% · 3.15M sh
Greenhaven Associates Inc
4.02% · 3.10M sh
Principal Global Investors, LLC
3.82% · 2.95M sh
MFS Investment Management
2.73% · 2.11M sh
Ruane, Cunniff & Goldfarb L.P.
2.65% · 2.05M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 25 buys · 19 sells
| Name | Role | Stake |
|---|---|---|
| Ciaran Murray | Independent Non-Executive Chairperson | 0.03% |
| Linda Grais | Independent Director | 0.01% |
| Nigel Clerkin | Chief Financial Officer | 0.01% |
| Barry Balfe | President of ICON Pharma Development Solutions | 0.01% |
| Ronan Murphy | Lead Independent Director | 0.00% |
| Eugene McCague | Independent Non-Executive Director | 0.00% |
| Julie O'Neill | Independent Non-Executive Director | 0.00% |
| John Climax | Founder & Independent Non-Executive Director | 0.00% |
| Anne Michelle Whitaker | Non-Executive Director | 0.00% |
| Lyons Emer | Chief Accounting Officer | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-16 | Eugene McCague | Independent Non-Executive Director | Derivative Exercise and Sale | -3,255 | $125.74–175.00 |
| 2026-09-16 | Ronan Murphy | Lead Independent Director | Derivative Exercise and Sale | -5,005 | $125.74–175.00 |
| 2026-09-15 | John Climax | Founder & Independent Non-Executive Director | Derivative Exercise and Sale | -5,005 | $125.74–175.00 |
| 2026-08-10 | John Climax | Founder & Independent Non-Executive Director | Derivative Exercise and Sale | -841 | $162.72–165.51 |
| 2026-08-10 | John Climax | Founder & Independent Non-Executive Director | Intent to Sell (Form 144) | -841 | $164.29 |
| 2026-08-10 | Linda Grais | Independent Director | Derivative Exercise and Sale | -841 | $162.72–165.51 |
| 2026-08-10 | Eugene McCague | Independent Non-Executive Director | Derivative Exercise and Sale | -841 | $162.72–165.51 |
| 2026-08-10 | Ciaran Murray | Independent Non-Executive Chairperson | Derivative Exercise and Sale | -2,677 | $162.72–165.51 |
| 2026-08-10 | Ciaran Murray | Independent Non-Executive Chairperson | Intent to Sell (Form 144) | -2,677 | $164.29 |
| 2026-08-10 | Nigel Clerkin | Chief Financial Officer | Derivative Exercise and Sale | -2,267 | $162.72–165.51 |
| 2026-08-10 | Nigel Clerkin | Chief Financial Officer | Intent to Sell (Form 144) | -2,267 | $164.29 |
| 2026-08-10 | Ronan Murphy | Lead Independent Director | Derivative Exercise and Sale | -841 | $162.72–165.51 |
| 2026-08-10 | Anne Michelle Whitaker | Non-Executive Director | Derivative Exercise and Sale | -841 | $162.72–165.51 |
| 2026-08-10 | Anne Michelle Whitaker | Non-Executive Director | Intent to Sell (Form 144) | -841 | $164.29 |
| 2026-08-10 | Julie O'Neill | Independent Non-Executive Director | Derivative Exercise and Sale | -915 | $162.72–165.51 |
| 2026-08-09 | John Climax | Founder & Independent Non-Executive Director | Other Derivative Acquisition | +1,324 | -- |
| 2026-08-09 | John Climax | Founder & Independent Non-Executive Director | Derivative Exercise and Retained | +891 | -- |
| 2026-08-09 | Linda Grais | Independent Director | Other Derivative Acquisition | +1,324 | -- |
| 2026-08-09 | Linda Grais | Independent Director | Derivative Exercise and Retained | +891 | -- |
| 2026-08-09 | Eugene McCague | Independent Non-Executive Director | Other Derivative Acquisition | +1,324 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.